SVB Leerink Maintains Outperform on NeoGenomics, Lowers Price Target to $45
SVB Leerink analyst Puneet Souda maintains NeoGenomics (NASDAQ:NEO) with a Outperform and lowers the price target from $50 to $45.
12 Health Care Stocks Moving In Tuesday’s After-Market Session
Gainers
China SXT Pharmaceuticals (NASDAQ:SXTC) stock rose 10.9% to $0.6 during Tuesday's after-market session. The market value of their outstanding shares is at $9.2 million.
Want To Buy Crypto? Check Out The Top Movers For Today
Pulled from Benzinga Pro here's the list of the top crypto gainers and losers at the time of publication:
IoTeX, NEM Among Top Crypto Movers In 24H
After pulling data from Benzinga Pro the following is the list of top crypto gainers and losers at the time of publication:
NeoGenomics Reports Will Leverage Thermo Fisher’s Ion Torrent Genexus System In Upcoming Phase 1 Study For Myeloid Cancers
NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced it will use Thermo Fisher Scientific's Ion Torrent Genexus
Analyst Ratings For NeoGenomics
Within the last quarter, NeoGenomics (NASDAQ:NEO) has observed the following analyst ratings:
Kadena, NEM Among Top Crypto Movers In 24H
According to Benzinga Pro, the following are the crypto gainers and losers at the time of publication:
Genetron Early Monday Reported Entered Strategic Partnership With NeoGenomics To Drive Global Oncology Drug Research, Development
Genetron Holdings Limited ((&ldquo, Genetron Health&rdquo, or the &ldquo, Company&rdquo, , NASDAQ:GTH), a leading precision oncology platform company in China that specializes in offering molecular profiling tests, early